Pharmaceutical

Yale and Transcend wins US DoD grant for PTSD therapy

The US Department of Defense grant is to study methylone for the rapid and long-lasting treatment of PTSD.

Sep 23, 2023 - 20:00
Yale and Transcend wins US DoD grant for PTSD therapy
The US Department of Defense grant is to study methylone for the rapid and long-lasting treatment of PTSD.
Read the original article

Tags:

Previous Article

Signal: CMR Surgical Raises $165m to continue development of surgical robot

Next Article

Novo Holdings acquires biopharma company Paratek for $462m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Intellia’s gene editing therapy shows early potential in rare heart condition

Intellia’s gene editing therapy shows early potential i...

Nov 19, 2024

STAT+: Three women sue cancer diagnostic firm Grail alleging harassment, retaliation

STAT+: Three women sue cancer diagnostic firm Grail all...

Jul 14, 2023

Heart Transplant Rejection drugs in development, 2023

Nov 30, 2023